ChemPartner PharmaTech Co.,Ltd. (SHE:300149)
China
· Delayed Price · Currency is CNY 10.15
-0.33 (-3.15%)
Last updated: Jun 5, 2025
ChemPartner PharmaTech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -194.37 | -226.47 | -916.75 | 378.59 | -402.25 | 154.55 | Upgrade
|
| Depreciation & Amortization | 130.09 | 130.09 | 139.62 | 192.79 | 194.33 | 103.61 | Upgrade
|
| Other Amortization | 49.45 | 49.45 | 50.37 | 55.54 | 54.4 | 43.28 | Upgrade
|
| Loss (Gain) From Sale of Assets | -8.43 | -8.43 | 0 | 0.15 | 0.02 | 0.03 | Upgrade
|
| Asset Writedown & Restructuring Costs | 160.75 | 160.75 | 867.18 | 545.29 | 373.27 | 42.58 | Upgrade
|
| Loss (Gain) From Sale of Investments | -7.8 | -7.8 | 0.92 | -1,391 | -11.05 | -94.25 | Upgrade
|
| Provision & Write-off of Bad Debts | 31.24 | 31.24 | 4.66 | 16.6 | 5.33 | 5.31 | Upgrade
|
| Other Operating Activities | -23.75 | 23.52 | 44.03 | 32.93 | 85.79 | 58.58 | Upgrade
|
| Change in Accounts Receivable | 58.81 | 58.81 | 78.67 | -107.3 | 64.96 | -103.89 | Upgrade
|
| Change in Inventory | 7.01 | 7.01 | 0.06 | -16.49 | -17.13 | 10.61 | Upgrade
|
| Change in Accounts Payable | -41.24 | -41.24 | -88.55 | 575.2 | 29.69 | 108.29 | Upgrade
|
| Operating Cash Flow | 153.03 | 168.21 | 150.99 | 262.46 | 378.22 | 343.16 | Upgrade
|
| Operating Cash Flow Growth | -22.27% | 11.40% | -42.47% | -30.61% | 10.22% | 59.56% | Upgrade
|
| Capital Expenditures | -44.1 | -69.25 | -201.29 | -336.2 | -286 | -394.03 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.16 | 0.16 | 0.14 | 0.61 | 0.41 | 0.02 | Upgrade
|
| Divestitures | - | - | 36.82 | 1,590 | 10 | - | Upgrade
|
| Investment in Securities | 1.22 | 1.19 | 150.92 | -163.65 | -15.62 | -18.02 | Upgrade
|
| Other Investing Activities | -3.59 | 0.23 | 0.59 | -82.7 | 80.32 | 5.02 | Upgrade
|
| Investing Cash Flow | -46.31 | -67.67 | -12.82 | 1,008 | -210.89 | -407.01 | Upgrade
|
| Long-Term Debt Issued | - | 58.45 | 107.95 | 368.3 | 394.77 | 642.3 | Upgrade
|
| Long-Term Debt Repaid | - | -141.41 | -490.05 | -1,183 | -549.98 | -483.17 | Upgrade
|
| Net Debt Issued (Repaid) | -82.96 | -82.96 | -382.1 | -815.08 | -155.21 | 159.13 | Upgrade
|
| Repurchase of Common Stock | - | - | - | -5.06 | -20.44 | - | Upgrade
|
| Common Dividends Paid | -1.97 | -2.88 | -6.24 | -37.4 | -81.14 | -57.1 | Upgrade
|
| Other Financing Activities | -9.11 | -0.6 | - | -2.56 | -2.56 | 12.13 | Upgrade
|
| Financing Cash Flow | -94.04 | -86.44 | -388.34 | -860.11 | -259.36 | 114.16 | Upgrade
|
| Foreign Exchange Rate Adjustments | 4.36 | 7.12 | 6.98 | 22.3 | -0.81 | -2.16 | Upgrade
|
| Net Cash Flow | 17.04 | 21.22 | -243.19 | 432.43 | -92.84 | 48.15 | Upgrade
|
| Free Cash Flow | 108.93 | 98.96 | -50.3 | -73.74 | 92.22 | -50.87 | Upgrade
|
| Free Cash Flow Growth | 111.02% | - | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 10.93% | 10.20% | -4.42% | -5.56% | 5.46% | -3.43% | Upgrade
|
| Free Cash Flow Per Share | 0.20 | 0.20 | -0.10 | -0.15 | 0.19 | -0.10 | Upgrade
|
| Cash Interest Paid | 0.6 | 0.6 | - | - | - | - | Upgrade
|
| Cash Income Tax Paid | - | -25.41 | -16.7 | -26.33 | -0.98 | 9.48 | Upgrade
|
| Levered Free Cash Flow | 79.7 | 51.11 | -76.32 | -190.37 | 75.59 | -374.91 | Upgrade
|
| Unlevered Free Cash Flow | 95.54 | 67.42 | -56.76 | -148.82 | 124.79 | -342.31 | Upgrade
|
| Change in Net Working Capital | -7.1 | -17.91 | 4.48 | 1.23 | -121.24 | 221.17 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.